✦ LIBER ✦

Anti-tumor necrosis factor-alpha antibody treatment reduces serum CXCL16 levels in patients with rheumatoid arthritis

✍ Scribed by Yasunori Kageyama; Eiji Torikai; Akira Nagano

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with anti-TNF-α antibody infli

✍ Yasunori Kageyama; Masaaki Takahashi; Eiji Torikai; Motohiro Suzuki; Tetsuya Ich 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 108 KB

Anti-tumor necrosis factor therapy incre

✍ Norio Komai; Yoshitaka Morita; Takeo Sakuta; Atsunori Kuwabara; Naoki Kashihara 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 280 KB

Decrease in the levels of anti-cyclic ci

✍ Sachiko Onishi; Taku Yoshio; Takao Nagashima; Seiji Minota 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 167 KB

Decrease in cellularity and expression o

✍ Paul P. Tak; Peter C. Taylor; Ferdinand C. Breedveld; Tom J. M. Smeets; Mohamed 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 882 KB

Reduction of NOS2 overexpression in rheu

✍ Douglas J. Perkins; E. William St. Clair; Mary A. Misukonis; J. Brice Weinberg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

Pneumocystis jirovecipneumonia in a pati

✍ Shunsuke Mori; Fumiya Imamura; Chikage Kiyofuji; Kanako Ito; Yukinori Koga; Izum 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 350 KB